HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caterina Uberti-Foppa Selected Research

Caterina Uberti-Foppa Research Topics

Disease

9Infections
02/2021 - 08/2002
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 01/2006
6Fibrosis (Cirrhosis)
01/2019 - 07/2007
6Coinfection
01/2019 - 11/2003
5HIV Infections (HIV Infection)
01/2017 - 08/2002
5Liver Diseases (Liver Disease)
03/2016 - 01/2006
4Disease Progression
01/2021 - 11/2003
4Chronic Hepatitis C
01/2019 - 07/2007
3COVID-19
01/2021 - 01/2020
3Hepatitis C
03/2016 - 05/2009
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2017
2Viremia
01/2022 - 06/2003
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2017 - 06/2003
2Hepatitis B
01/2017 - 11/2009
2Acquired Immunodeficiency Syndrome (AIDS)
01/2013 - 11/2008
2Papillomavirus Infections
05/2006 - 02/2005
1Inflammation (Inflammations)
12/2020
1Chronic Disease (Chronic Diseases)
12/2020
1Cytokine Release Syndrome
12/2020
1Pneumonia (Pneumonitis)
01/2020
1Chronic Hepatitis B
10/2019
1Hematologic Diseases (Blood Diseases)
01/2019
1Chronic Renal Insufficiency
01/2019
1Anorexia
12/2014
1Nausea
12/2014
1Liver Failure
11/2009
1Tuberculosis (Tuberculoses)
11/2008
1Kaposi Sarcoma (Kaposi's Sarcoma)
11/2008
1Neoplasms (Cancer)
01/2008
1Cerebrospinal Fluid Leak
01/2008
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2006
1Necrosis
01/2006
1Visceral Leishmaniasis (Kala Azar)
11/2003
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
08/2002
1Opportunistic Infections (Opportunistic Infection)
08/2002
1Cryptococcosis
08/2002
1Toxoplasmosis
08/2002
1Cerebral Toxoplasmosis
08/2002

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2005
5Antiviral Agents (Antivirals)IBA
07/2017 - 11/2009
5Ribavirin (Virazole)FDA LinkGeneric
07/2017 - 10/2014
4RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
4AntibodiesIBA
01/2020 - 06/2006
3InterferonsIBA
07/2017 - 10/2014
3Pharmaceutical PreparationsIBA
10/2014 - 07/2007
2Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 01/2008
2CytokinesIBA
12/2020 - 01/2006
2SimeprevirIBA
07/2017 - 01/2017
2SofosbuvirIBA
07/2017 - 01/2017
2Alanine Transaminase (SGPT)IBA
10/2016 - 01/2006
2Protease Inhibitors (Protease Inhibitor)IBA
12/2014 - 10/2014
2telaprevirIBA
12/2014 - 10/2014
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2021
1PhytochemicalsIBA
12/2020
1Plant ExtractsIBA
12/2020
1PolyphenolsIBA
12/2020
1AntioxidantsIBA
12/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Viral RNAIBA
01/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2019
1Calcitonin Gene-Related PeptideIBA
01/2019
1glecaprevir and pibrentasvirIBA
01/2019
1elbasvirIBA
07/2017
1daclatasvirIBA
07/2017
1grazoprevirIBA
07/2017
1Amino AcidsFDA Link
07/2017
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2017
1dolutegravirIBA
01/2017
1Rilpivirine (TMC-278)IBA
01/2017
1AntigensIBA
01/2017
1Hepatitis B Core AntigensIBA
01/2017
1Codon (Codons)IBA
01/2017
1VaccinesIBA
01/2017
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
10/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2013
1Alanine (L-Alanine)FDA Link
05/2010
1Transaminases (Aminotransferases)IBA
05/2010
1C-Type Lectins (C-Type Lectin)IBA
07/2009
1HCV NS3-4A Protease InhibitorsIBA
05/2009
1Reverse Transcriptase InhibitorsIBA
11/2008
1NucleosidesIBA
11/2008
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
07/2007
1Interferon-gamma (Interferon, gamma)IBA
01/2006
1Messenger RNA (mRNA)IBA
01/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1Interleukin-10 (Interleukin 10)IBA
01/2006
1DNA (Deoxyribonucleic Acid)IBA
11/2003

Therapy/Procedure

10Therapeutics
12/2014 - 08/2002
5Highly Active Antiretroviral Therapy (HAART)
01/2019 - 06/2006
2Neurosurgical Procedures
02/2021 - 01/2008
2Duration of Therapy
01/2019 - 07/2017
1Cell Transplantation
01/2019
1Art Therapy
08/2013
1Liver Transplantation
11/2009
1Craniotomy
01/2008
1Aftercare (After-Treatment)
11/2003